Effect of Smoking Cessation on Tuberculosis Treatment Outcomes

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

292 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-11-06

Study Completion Date

2019-10-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was a Randomized Controlled Trial conducted at Ojha Institute of Chest Diseases, Dow University of Health Sciences, Karachi, among pulmonary tuberculosis patients

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases

NCT05764343

Tobacco Cessation Asthma COPD Bronchiectasis Adult

COMPLETED NA

Brief Tobacco Cessation Intervention

NCT02494960

Smoking

COMPLETED NA

Smoking Cessation Intervention: Effectiveness in Primary Care

NCT00296647

Tobacco Dependence

COMPLETED PHASE4

Smoking Cessation Program: A Quality Improvement Trial in a Resident-Based Outpatient Clinic

NCT00436943

Smoking

TERMINATED

A Comparative Effectiveness RCT of Optimized Cessation Treatments

NCT02301403

Smoking Cessation

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tuberculosis, Pulmonary

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

A total of three groups, two intervention and one control

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Outcome assessor for tuberculosis outcomes at the study site were blinded in terms of intervention allocation

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bupropion

Group Type EXPERIMENTAL

Bupropion

Intervention Type DRUG

This group received Bupropion 150 mg twice daily for 10 weeks

Behavioural Change Communication

Intervention Type BEHAVIORAL

This group will receive Behavioural Change Communication

Behavioural Change Communication

Group Type EXPERIMENTAL

Behavioural Change Communication

Intervention Type BEHAVIORAL

This group will receive Behavioural Change Communication

Control

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bupropion

This group received Bupropion 150 mg twice daily for 10 weeks

Intervention Type DRUG

Behavioural Change Communication

This group will receive Behavioural Change Communication

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* pulmonary tuberculosis patients of age 18 years or above
* registered under Directly Observed Treatment Short course (DOTS) at Ojha Institute of Chest Diseases
* reported to have smoked 100 plus cigarettes in past and currently smoking cigarettes